Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiome -- CRME -- Ignore unavailable to you. Want to Upgrade?

To: rareearth42 who wrote (42)	7/29/2006 6:16:36 PM
From: former_pgs	Read Replies (2) \| Respond to of 285

OT: >PGS, is that you?< Maybe. Maybe not. >Did you graduate?< Maybe. Maybe not. >You should still be "P"< I should? Thanks... >unless your investments have paid off handsomely......< Maybe they have. Maybe they haven't. Nonetheless, I don't follow biotechs for the money.

To: rareearth42 who wrote (42)	7/31/2006 8:51:37 AM
From: kenhott	Read Replies (1) \| Respond to of 285

<CRME might get lucky, but I doubt it. I think there are much better opportunities in biotech right now.> I went to an antique roadshow taping not that long ago and one person's trash is another person's antique. Time will tell all. BTW, to the board, I heard the same thing mentioned on the conference call that the FDA asked SNY's Multaq for additional data.